Both in Biotechnology
Halozyme Therapeutics vs Kymera Therapeutics
Over the past year HALO returned +94.3% and KYMR returned +112.8%; their daily moves had a correlation of 0.16.
HALO +94.3% KYMR +112.8%Growth of $1, one year, split-adjusted
| Metric | HALO | KYMR |
|---|---|---|
| Price | $128.62 | $127.09 |
| Market cap | $14.60B | $10.85B |
| Today | −0.26% | −0.33% |
| 1 month | +18.8% | +15.7% |
| 6 months | +95.3% | +53.7% |
| Year to date | +91.1% | +63.3% |
| 1 year | +97.3% | +105.5% |
| Revenue growth (YoY) | +47.7% | −100.0% |
| Gross margin | 83.5% | — |
| Net margin | 47.8% | — |
| P/E (TTM) | 35.3× | — |
| Price / sales | 8.8× | 106.1× |
| Net cash | -$1.92B | $969.2M |
| Dividend yield | — | — |
| Volatility (60d) | 27.8% | 38.9% |
| Short % of float | 12.4% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).